Ipamorelin: Research Overview

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue (GHS) that mimics the action of ghrelin at the growth hormone secretagogue receptor (GHSR-1a). Developed in the late 1990s, Ipamorelin was notable for its high selectivity — it stimulates GH release with minimal impact on prolactin, cortisol, or ACTH secretion, a profile that distinguished it from earlier GHS compounds. This selectivity has made it a valuable research tool for studying the GH axis and its downstream effects on metabolism, body composition, and aging.

Mechanism of Action

Ipamorelin binds to the GHSR-1a receptor, a G-protein coupled receptor found predominantly in the hypothalamus and pituitary gland. Receptor activation triggers a signaling cascade that results in pulsatile GH secretion from the anterior pituitary. Unlike GHRH analogues, Ipamorelin works through a distinct receptor system but achieves complementary GH-releasing effects. Its selectivity for the GH axis — with low affinity for other receptor systems that earlier ghrelin mimetics activated — means that studies using Ipamorelin can more cleanly isolate GH-mediated effects from confounding hormonal changes.

Key Research Areas

• Growth Hormone Axis Studies: Ipamorelin is used to study pulsatile GH release patterns and the downstream effects of GH on IGF-1 production in both in vitro and in vivo models.
• Body Composition Research: Animal studies have examined Ipamorelin’s effects on lean mass preservation, fat metabolism, and overall body composition in various metabolic contexts.
• Bone Density Models: Research has explored GH secretagogue effects on bone mineral density and osteoblast activity, using Ipamorelin as a model compound due to its clean hormonal profile.
• Aging and GH Deficiency Models: Preclinical studies have used Ipamorelin in aged rodents to examine how GH secretagogue stimulation affects age-related physiological decline markers.

Research Applications

Ipamorelin is used in endocrinology and metabolic research as a selective tool for stimulating GH release without confounding effects on other pituitary hormones. It is administered subcutaneously in rodent models and is often combined with GHRH analogues (such as CJC-1295) in studies designed to achieve synergistic GH stimulation. In cell-based assays, it is used to examine GHSR signaling and downstream pathway activation in pituitary cell lines.

Storage and Handling

Ipamorelin is provided as a lyophilized powder for research use. Store at -20°C, protected from moisture and light. Reconstitute with sterile bacteriostatic water under aseptic conditions. Once in solution, store at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles to maintain peptide activity.

Available from Alpha Peptides US

Alpha Peptides US offers Ipamorelin 10mg for qualified research use. Suitable for GH axis studies, endocrinology, and metabolic research protocols.

This product is intended for laboratory research purposes only. It is not approved by the FDA and is not intended for human or veterinary use, diagnosis, treatment, or prevention of any condition.